MENU
EDSA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Edesa Biotech (EDSA) Earnings Date & Reports

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases... Show more

A.I. Advisor
published Earnings

EDSA is expected to report earnings to fall 47.77% to -15 cents per share on December 13

Edesa Biotech EDSA Stock Earnings Reports
Q3'23
Est.
$-0.16
Q1'25
Beat
by $0.08
Q2'23
Beat
by $0.06
Q1'23
Est.
$-0.12
Q4'22
Beat
by $0.05
The last earnings report on May 14 showed earnings per share of -30 cents, beating the estimate of -37 cents. With 40.05K shares outstanding, the current market capitalization sits at 12.85M.
View a ticker or compare two or three
EDSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Spy Court
Phone
+1 289 800-9600
Employees
16
Web
https://www.edesabiotech.com